Holen Sie sich die Stockscreener-App
56.27
2.39%
1.3157
Schlusskurs vom Vortag:
$54.96
Offen:
$54.85
24-Stunden-Volumen:
52,079
Relative Volume:
3.92
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+8.07%
1M Leistung:
+19.68%
6M Leistung:
+19.21%
1J Leistung:
+67.37%
1-Tages-Spanne:
$54.85
$56.77
1-Wochen-Bereich:
$51.30
$56.77
52-Wochen-Spanne:
$33.38
$56.77
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Firmenname
Global X Genomics Biotechnology Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare GNOM vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
56.27 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
362.22 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
728.99 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
730.17 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
299.49 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
706.52 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf Aktie (GNOM) Neueste Nachrichten
Global X Fds Genomics & Biotechnology Etf To Go Ex-Dividend On June 29th, 2026 With 0.05789 USD Dividend Per Share - 富途牛牛
Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead? - TradingView
Pacific Biosciences of California Inc (PACB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Illumina Inc (ILMN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
2Seventy Bio Inc (TSVT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biontech SE (BNTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
WAVE Life Sciences Ltd (WVE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Moderna Inc (MRNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Uniqure NV (QURE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bio-Techne Corp (TECH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CARGO Therapeutics Inc (CRGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Veracyte Inc (VCYT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Beam Therapeutics Inc (BEAM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ultragenyx Pharmaceutical Inc (RARE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Natera Inc (NTRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CareDx Inc (CDNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BioMarin Pharmaceutical Inc (BMRN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CureVac NV (CVAC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sangamo Therapeutics Inc (SGMO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Avidity Biosciences Inc (RNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rocket Pharmaceuticals Inc (RCKT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Qiagen NV (QGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Personalis Inc (PSNL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Allogene Therapeutics Inc (ALLO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CRISPR Therapeutics AG (CRSP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sarepta Therapeutics Inc (SRPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sana Biotechnology Inc (SANA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vir Biotechnology Inc (VIR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Twist Bioscience Corp (TWST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alnylam Pharmaceuticals Inc (ALNY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arcturus Therapeutics Holdings Inc (ARCT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Prime Medicine Inc (PRME) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Intellia Therapeutics Inc (NTLA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Price-Driven Insight from (GNOM) for Rule-Based Strategy - Stock Traders Daily
(GNOM) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
5 Small-cap Biotech ETFs to Watch in 2026 - Investing News Network
(GNOM) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Emerge launches five innovation-focused ETFs - Advisor.ca
Why Is Global XGenomics & Biotechnology ETF (GNOM) Stock Up Today? - Meyka
(GNOM) Risk Channels and Responsive Allocation - Stock Traders Daily
Best CRISPR Gene Editing ETFs for 2026 and How to Invest - The Motley Fool
Global X Rare Earth & Critical Materials ETF (EART) Short Interest & Short Float | Updated May 2026 - MarketBeat
GNMX Stock Fund Price and Chart — CBOE:GNMX - TradingView
Beyond tech industry: Here's how biotech ETFs are riding the AI wave - MSN
(GNOM) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Global X Fds Genomics & Biotechnology Etf | NPORT-P: Others - Moomoo
Liquidity Mapping Around (GNOM) Price Events - Stock Traders Daily
The Next Big Theme: April 2026 - Global X ETFs
Stock List: Research Stocks from Around the World - GuruFocus
GNOMZ ETF Holdings List — AQUISUK:GNOMZ - TradingView
GNOMZ ETF Analysis: Dividends, Returns AQUISUK:GNOMZ - TradingView
Finanzdaten der Global X Genomics Biotechnology Etf-Aktie (GNOM)
Es liegen keine Finanzdaten für Global X Genomics Biotechnology Etf (GNOM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):